New Onset Migraine With Aura Following Head Injury: A Case Report

Husid, Marc S.

doi:10.1111/j.1526-4610.2004.4200_3.x

Cited by 7 publications

(8 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This case describes BTM aborted with GON blockade given because of prominent ipsilateral suboccipital tenderness noted on exam. GON blockade can alleviate migraine headache as well as aura 12 . Cessation of HPM auras with GON blockade was also reported in 2 patients 13 with rapid response very similar to the response we witnessed in our patient.…”

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Acute Treatment of Basilar‐Type Migraine With Greater Occipital Nerve Blockade

et al. 2010

View full text Add to dashboard Cite

Basilar-type migraine (BTM) precludes use of migraine-specific medications such as triptans and ergots based on concerns originating from the vascular theory of migraine, although data supporting this contraindication are lacking. Availability of effective treatments for acute BTM is limited. We report a case of BTM aborted with greater occipital nerve (GON) blockade given in the setting of prominent suboccipital tenderness. GON blockade may provide an additional option in acute management of BTM. It may be particularly useful when associated with prominent ipsilateral suboccipital tenderness.

show abstract

Section: Discussionsupporting

confidence: 89%

“…GON blockade can alleviate migraine headache as well as aura. 12 Cessation of HPM auras with GON blockade was also reported in 2 patients 13 with rapid response very similar to the response we witnessed in our patient.…”

Section: Discussionsupporting

confidence: 89%

Acute Treatment of Basilar‐Type Migraine With Greater Occipital Nerve Blockade

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Cilostazol suppresses the expression of heparinbinding epidermal growth factor-like growth factor in lipopolysaccharide (LPS)-stimulated smooth muscle cells and macrophages [Kayanoki et al, 1997] and reduces superoxide anion formation and nuclear factor-kB (NF-kB) activation in high cholesterol-fed mice . Cilostazol also suppresses hyperplasia formation in balloon-injured rat arteries , prevents restenosis after coronary stent implantation by inhibiting Mac-1-leukocytes [Husid, 2004], and inhibits platelet-derived growth factor-stimulated cell proliferation by increasing cAMP levels and inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway [Matousovic et al, 1995]. Because PDE3 activity and expression increase significantly in the aorta of atherosclerosis-prone insulin-resistant rats [Thomas et al, 1990], inhibition of PDE3 may be therapeutically useful for treating and preventing atherosclerosis.…”

mentioning

confidence: 96%

Cilostazol attenuates MCP‐1 and MMP‐9 expression in vivo in LPS‐administrated balloon‐injured rabbit aorta and in vitro in LPS‐treated monocytic THP‐1 cells

Tsai

Lin

Chen

et al. 2007

J of Cellular Biochemistry

View full text Add to dashboard Cite

Monocyte chemoattractant protein-1 (MCP-1) and matrix metalloproteinase-9 (MMP-9) are involved in vascular inflammation. We tested the hypothesis, and explored the underlining mechanisms that cilostazol, a phosphodiesterase 3 inhibitor with antiplatelet and antithrombotic properties, inhibits lipopolysaccharide (LPS)-induced MCP-1 and MMP-9 expression. In a rabbit aorta balloon-injury model, administration of LPS increased macrophage infiltration and MCP-1 and MMP-9 expression; cilostazol supplementation prevented this phenomenon and reduced intimal hyperplasia. In contrast, the reverse zymography showed that cilostazol did not affect TIMP-1 expression in serum. In monocytic THP-1 cells, cilostazol and N6,O2'-dibutyryl-cAMP (dioctanoyl-cAMP, a cAMP analog) dose-dependently inhibited LPS-induced MCP-1 protein expression and MMP-9 activation, but did not affect the tissue inhibitor of metalloproteinase-1. Quantitative real-time polymerase chain reaction (PCR) showed that cilostazol inhibited MCP-1 and MMP-9 mRNA expression. Cilostazol significantly inhibited LPS-induced activation of p38, JNK, and nuclear factor-kappaB, and the respective inhibitors of p38 and JNK greatly reduced the level of LPS-induced MCP-1 and MMP-9, suggesting the involvement of the p38 and JNK pathways. In conclusion, cilostazol administered with LPS in vivo reduced neointimal hyperplasia and macrophage infiltration in the balloon-injured rabbit aorta; in vitro, cilostazol inhibits LPS-induced MCP-1 and MMP-9 expression. These data suggest that cilostazol may play an important role in preventing endotoxin- and injured-mediated vascular inflammation.

show abstract

“…Glutamate is a stimulator of CSD in laboratory studies 9 . Greater occipital nerve blockade (GON) can alleviate the pain of migraine and in 1 case report the migraine aura 10 . The results of GON blockade on the hemiplegic migraine aura and prolonged auras has not yet been studied.…”

mentioning

confidence: 99%

Cessation of Hemiplegic Migraine Auras With Greater Occipital Nerve Blockade

Rozen¹

2007

Headache

View full text Add to dashboard Cite

Prolonged migraine auras can be disabling and potentially can cause permanent neurologic deficits. Several medicinal agents have shown some efficacy in aborting prolonged auras, but results are inconsistent. Greater occipital nerve blockade can alleviate the pain of migraine and in 1 case report the migraine aura. Hemiplegic migraine attacks are marked by motor weakness that can last for minutes to days. Two case patients with a history of hemiplegic migraine with prolonged auras are presented, who both had complete alleviation of their aura symptoms with GON blockade. A hypothesis on how GON blockade may inhibit cortical spreading depression is also presented.

show abstract

New Onset Migraine With Aura Following Head Injury: A Case Report

Cited by 7 publications

References 14 publications

Acute Treatment of Basilar‐Type Migraine With Greater Occipital Nerve Blockade

Acute Treatment of Basilar‐Type Migraine With Greater Occipital Nerve Blockade

Cilostazol attenuates MCP‐1 and MMP‐9 expression in vivo in LPS‐administrated balloon‐injured rabbit aorta and in vitro in LPS‐treated monocytic THP‐1 cells

Cessation of Hemiplegic Migraine Auras With Greater Occipital Nerve Blockade

Contact Info

Product

Resources

About